Astrazeneca Plc Adr Stock Net Asset
| 0A4J Stock | 67.09 0.33 0.49% |
AstraZeneca PLC ADR fundamentals help investors to digest information that contributes to AstraZeneca PLC's financial success or failures. It also enables traders to predict the movement of AstraZeneca Stock. The fundamental analysis module provides a way to measure AstraZeneca PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AstraZeneca PLC stock.
AstraZeneca | Net Asset |
AstraZeneca PLC ADR Company Net Asset Analysis
AstraZeneca PLC's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
AstraZeneca Total Assets
Total Assets |
|
Based on the recorded statements, AstraZeneca PLC ADR has a Net Asset of 0.0. This indicator is about the same for the Commercial Services & Supplies average (which is currently at 0.0) sector and about the same as Industrials (which currently averages 0.0) industry. This indicator is about the same for all United Kingdom stocks average (which is currently at 0.0).
AstraZeneca Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AstraZeneca PLC's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AstraZeneca PLC could also be used in its relative valuation, which is a method of valuing AstraZeneca PLC by comparing valuation metrics of similar companies.AstraZeneca PLC is currently under evaluation in net asset category among its peers.
AstraZeneca Fundamentals
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.085 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 131.46 B | ||||
| Shares Owned By Institutions | 16.75 % | ||||
| Revenue | 51.21 B | ||||
| Gross Profit | 35.73 B | ||||
| EBITDA | 18.39 B | ||||
| Net Income | 5.96 B | ||||
| Book Value Per Share | 26.27 X | ||||
| Cash Flow From Operations | 9.81 B | ||||
| Earnings Per Share | (0.36) X | ||||
| Target Price | 71.9 | ||||
| Number Of Employees | 89.9 K | ||||
| Beta | 0.18 | ||||
| Retained Earnings | 3.12 B | ||||
| Annual Yield | 0.0002 % | ||||
| Last Dividend Paid | 2.97 |
About AstraZeneca PLC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AstraZeneca PLC ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AstraZeneca PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AstraZeneca PLC ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for AstraZeneca Stock Analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.